12/05/2011 - 2:33pm

With consumers eating more meals at home, frozen food sales are soaring. Packaged Facts predicted the frozen food category will grow to $70 billion in 2015, an increase of $14.1 billion (or 25%) over 2010.

12/05/2011 - 9:43am

Alkaline batteries are showing tepid growth, and experts expect sales to plunge as much as 3% as fierce competition among manufacturers continues to pressure pricing. More devices are using built-in rechargeable battery systems — another trend hurting primary battery sales.


12/05/2011 - 9:42am

Sales of carbonated beverages remain stagnant, but sales of energy drinks, sports drinks and functional waters have seen gains over the last quarter. Sales of ready-to-drink tea and yogurt drinks and smoothies also are segments showing promise.


12/05/2011 - 9:42am

Fragrance sales appear to be on the rise, and the outlook looks especially positive with the gifting season upon us.


12/05/2011 - 9:42am

Recent research indicates that there is a growing natural hair trend among African-American women in the United States, with a shift from relaxed to natural becoming so common that it has sparked growth of those hair care products that help hair “transition.”


12/05/2011 - 9:42am

The holidays stand as prime time heartburn season with Thanksgiving dinners and holiday get-togethers on the calendar. And that doesn’t even cover the obligatory holiday fruitcakes.


12/05/2011 - 9:42am

One of the factors behind the success of homeopathy in mass retail is social media, both by way of Facebook and mommy bloggers.


12/05/2011 - 9:42am

Safe and effective. Those are the selling points that homeopathy has been emphasizing with mass consumers, and it’s working. Sales of homeopathic products as measured by SPINSscan across food, drug and mass (excluding Walmart) were up 16%, reaching a sales base of $126.1 million.

11/14/2011 - 12:39pm

The National Community Pharmacists Association in October released results from a survey of more than 800 independent community pharmacists about the negative consequences for their patients and their businesses if diabetes testing supplies under Medicare Part B are subjected to competitive bidding prices.